Study finds no shortage of misleading HPV vaccine websites

Research published by the Journal of Adolescent Health demonstrates a reality that Big Pharmas Merck & Co. ($MRK) and GlaxoSmithKline ($GSK) have experienced for years: There's an abundance of misinformation circulating about HPV vaccines. A team led by Dr. Linda Fu at George Washington University completed 20 different searches using a variety of terms linked with HPV vaccines and came across 116 websites, 39% of which were critical. In some cases, the misleading or incomplete sites highlighted safety concerns with the vaccines and contended that the vaccines encourage sexual activity, two misperceptions that have hampered uptake and dragged on sales in the vaccine category for some time. More from FierceVaccines

Suggested Articles

Leaked details about an ad campaign to quell coronavirus fears before the election raise "every red flag I could dream of," an ex-HHS official said.

The FDA approved GlaxoSmithKline's Nucala to treat hypereosinophilic syndrome, making it the first biologic approved for that disease.

There’s an emerging trend within the SMA community to pair treatments up in the hope that they may provide even better outcomes, one analyst notes.